• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多能干细胞衍生的心肌细胞再现了心脏钠离子通道病重叠综合征的电生理特征。

Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease.

机构信息

Department of Anatomy and Embryology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands.

出版信息

Circulation. 2012 Jun 26;125(25):3079-91. doi: 10.1161/CIRCULATIONAHA.111.066092. Epub 2012 May 30.

DOI:10.1161/CIRCULATIONAHA.111.066092
PMID:22647976
Abstract

BACKGROUND

Pluripotent stem cells (PSCs) offer a new paradigm for modeling genetic cardiac diseases, but it is unclear whether mouse and human PSCs can truly model both gain- and loss-of-function genetic disorders affecting the Na(+) current (I(Na)) because of the immaturity of the PSC-derived cardiomyocytes. To address this issue, we generated multiple PSC lines containing a Na(+) channel mutation causing a cardiac Na(+) channel overlap syndrome.

METHOD AND RESULTS

Induced PSC (iPSC) lines were generated from mice carrying the Scn5a(1798insD/+) (Scn5a-het) mutation. These mouse iPSCs, along with wild-type mouse iPSCs, were compared with the targeted mouse embryonic stem cell line used to generate the mutant mice and with the wild-type mouse embryonic stem cell line. Patch-clamp experiments showed that the Scn5a-het cardiomyocytes had a significant decrease in I(Na) density and a larger persistent I(Na) compared with Scn5a-wt cardiomyocytes. Action potential measurements showed a reduced upstroke velocity and longer action potential duration in Scn5a-het myocytes. These characteristics recapitulated findings from primary cardiomyocytes isolated directly from adult Scn5a-het mice. Finally, iPSCs were generated from a patient with the equivalent SCN5A(1795insD/+) mutation. Patch-clamp measurements on the derivative cardiomyocytes revealed changes similar to those in the mouse PSC-derived cardiomyocytes.

CONCLUSION

Here, we demonstrate that both embryonic stem cell- and iPSC-derived cardiomyocytes can recapitulate the characteristics of a combined gain- and loss-of-function Na(+) channel mutation and that the electrophysiological immaturity of PSC-derived cardiomyocytes does not preclude their use as an accurate model for cardiac Na(+) channel disease.

摘要

背景

多能干细胞 (PSC) 为遗传心脏疾病的建模提供了新的范例,但由于 PSC 衍生的心肌细胞不成熟,尚不清楚小鼠和人类 PSC 是否真的可以模拟同时影响钠电流 (I(Na)) 的获得性功能和丧失性功能的遗传疾病。为了解决这个问题,我们生成了多个包含导致心脏钠离子通道重叠综合征的钠离子通道突变的 PSC 系。

方法和结果

从携带 Scn5a(1798insD/+) (Scn5a-het) 突变的小鼠中生成诱导多能干细胞 (iPSC) 系。这些小鼠 iPSC 与野生型小鼠 iPSC 进行了比较,同时还与用于生成突变小鼠的靶向小鼠胚胎干细胞系和野生型小鼠胚胎干细胞系进行了比较。膜片钳实验表明,与 Scn5a-wt 心肌细胞相比,Scn5a-het 心肌细胞的 I(Na) 密度显著降低,持续 I(Na) 增大。动作电位测量显示 Scn5a-het 心肌细胞的上升速度降低,动作电位时程延长。这些特征再现了直接从成年 Scn5a-het 小鼠分离的原代心肌细胞的发现。最后,从患有等效 SCN5A(1795insD/+) 突变的患者中生成了 iPSC。衍生的心肌细胞的膜片钳测量显示出与小鼠 PSC 衍生的心肌细胞相似的变化。

结论

在这里,我们证明胚胎干细胞和 iPSC 衍生的心肌细胞都可以再现复合获得性功能和丧失性功能钠离子通道突变的特征,并且 PSC 衍生的心肌细胞的电生理不成熟并不排除它们作为心脏钠离子通道疾病的准确模型的使用。

相似文献

1
Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease.多能干细胞衍生的心肌细胞再现了心脏钠离子通道病重叠综合征的电生理特征。
Circulation. 2012 Jun 26;125(25):3079-91. doi: 10.1161/CIRCULATIONAHA.111.066092. Epub 2012 May 30.
2
Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro.诱导多能干细胞来源的长 QT 综合征 3 型心肌细胞在体外再现典型的疾病特异性特征。
Circ Res. 2011 Sep 30;109(8):841-7. doi: 10.1161/CIRCRESAHA.111.243139. Epub 2011 Jul 28.
3
Anti-arrhythmic potential of the late sodium current inhibitor GS-458967 in murine Scn5a-1798insD+/- and human SCN5A-1795insD+/- iPSC-derived cardiomyocytes.GS-458967 对晚期钠电流抑制剂在 Scn5a-1798insD+/- 小鼠和 SCN5A-1795insD+/- 人类 iPSC 衍生心肌细胞中的抗心律失常作用。
Cardiovasc Res. 2017 Jun 1;113(7):829-838. doi: 10.1093/cvr/cvx077.
4
Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD.携带人类SCN5A-1795insD等效突变的小鼠心脏钠通道疾病重叠综合征
Circulation. 2006 Dec 12;114(24):2584-94. doi: 10.1161/CIRCULATIONAHA.106.653949. Epub 2006 Dec 4.
5
Disease characterization using LQTS-specific induced pluripotent stem cells.使用长 QT 综合征特异性诱导多能干细胞进行疾病特征描述。
Cardiovasc Res. 2012 Sep 1;95(4):419-29. doi: 10.1093/cvr/cvs206. Epub 2012 Jun 27.
6
Modeling genetic cardiac channelopathies using induced pluripotent stem cells - Status quo from an electrophysiological perspective.使用诱导多能干细胞对遗传性心脏通道病进行建模——从电生理学角度看现状。
Biochem Pharmacol. 2021 Oct;192:114746. doi: 10.1016/j.bcp.2021.114746. Epub 2021 Aug 27.
7
Switch From Fetal to Adult Isoform in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Unmasks the Cellular Phenotype of a Conduction Disease-Causing Mutation.人诱导多能干细胞衍生心肌细胞中从胎儿型到成人型异构体的转换揭示了一种导致传导疾病的突变的细胞表型。
J Am Heart Assoc. 2017 Jul 24;6(7):e005135. doi: 10.1161/JAHA.116.005135.
8
Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.运用动态动作电位钳技术探究长QT综合征相关的钠通道突变
J Physiol. 2006 Jan 15;570(Pt 2):237-50. doi: 10.1113/jphysiol.2005.096578. Epub 2005 Oct 27.
9
Ontogenic development of cardiomyocytes derived from transgene-free human induced pluripotent stem cells and its homology with human heart.无转基因的人诱导多能干细胞衍生的心肌细胞的个体发生发育及其与人心脏的同源性。
Life Sci. 2013 Jan 17;92(1):63-71. doi: 10.1016/j.lfs.2012.10.020. Epub 2012 Nov 7.
10
Generation of functional cardiomyocytes from mouse induced pluripotent stem cells.从诱导多能干细胞生成功能性心肌细胞。
Int J Cardiol. 2011 Dec 15;153(3):277-85. doi: 10.1016/j.ijcard.2010.08.052. Epub 2010 Sep 25.

引用本文的文献

1
A Better Understanding of Atrial-like and Ventricular-like Action Potentials in Stem Cell-Derived Cardiomyocytes: The Underestimated Role of the L-Type Ca Current.更好地理解干细胞衍生心肌细胞中的心房样和心室样动作电位:L型钙电流被低估的作用
Cells. 2025 Aug 8;14(16):1226. doi: 10.3390/cells14161226.
2
The identification of adenylyl cyclase modulators as potential receptors for 6-nitrodopamine in human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes and their relevance in heart inotropism.在人诱导多能干细胞(hiPSC)衍生的心肌细胞中鉴定腺苷酸环化酶调节剂作为6-硝基多巴胺的潜在受体及其在心脏变力性中的相关性。
Front Pharmacol. 2025 Aug 11;16:1597035. doi: 10.3389/fphar.2025.1597035. eCollection 2025.
3
Induced Pluripotent Stem Cells in Congenital Long QT Syndrome: Research Progress and Clinical Applications.
先天性长QT综合征中的诱导多能干细胞:研究进展与临床应用
Rev Cardiovasc Med. 2025 Apr 22;26(4):28251. doi: 10.31083/RCM28251. eCollection 2025 Apr.
4
Engineered In Vitro Multi-Cell Type Ventricle Model Generates Long-Term Pulsatile Flow and Modulates Cardiac Output in Response to Cardioactive Drugs.工程化体外多细胞类型心室模型可产生长期搏动血流并响应心脏活性药物调节心输出量。
Adv Healthc Mater. 2025 Apr;14(10):e2403897. doi: 10.1002/adhm.202403897. Epub 2025 Feb 13.
5
The Role of Human-Induced Pluripotent Stem Cells in Studying Cardiac Channelopathies.人诱导多能干细胞在研究心脏通道病中的作用。
Int J Mol Sci. 2024 Nov 8;25(22):12034. doi: 10.3390/ijms252212034.
6
Recent advancements of human iPSC derived cardiomyocytes in drug screening and tissue regeneration.人诱导多能干细胞衍生心肌细胞在药物筛选和组织再生方面的最新进展。
Microphysiol Syst. 2020 Sep;4:2. doi: 10.21037/mps-20-3. Epub 2020 Sep 15.
7
iPSC-cardiomyocytes in the preclinical prediction of candidate pharmaceutical toxicity.诱导多能干细胞衍生的心肌细胞在候选药物毒性的临床前预测中的应用
Front Pharmacol. 2024 Feb 28;15:1308217. doi: 10.3389/fphar.2024.1308217. eCollection 2024.
8
Engineered tissue geometry and Plakophilin-2 regulate electrophysiology of human iPSC-derived cardiomyocytes.工程化组织几何结构和桥粒斑蛋白-2调节人诱导多能干细胞衍生心肌细胞的电生理学。
APL Bioeng. 2024 Mar 11;8(1):016118. doi: 10.1063/5.0160677. eCollection 2024 Mar.
9
Hypertrophic cardiomyopathy dysfunction mimicked in human engineered heart tissue and improved by sodium-glucose cotransporter 2 inhibitors.肥厚型心肌病功能障碍在人源工程心脏组织中得到模拟,并通过钠-葡萄糖共转运蛋白 2 抑制剂得到改善。
Cardiovasc Res. 2024 Mar 14;120(3):301-317. doi: 10.1093/cvr/cvae004.
10
Preclinical Models of Cardiac Disease: A Comprehensive Overview for Clinical Scientists.心脏疾病的临床前模型:临床科学家的综合概述。
Cardiovasc Eng Technol. 2024 Apr;15(2):232-249. doi: 10.1007/s13239-023-00707-w. Epub 2024 Jan 16.